<DOC>
	<DOCNO>NCT00938301</DOCNO>
	<brief_summary>The purpose first human ( FIH ) study investigate safety , tolerability , pharmacokinetics ( body handle drug ) pharmacodynamics ( drug affect body ) PF-04455242-01 healthy adult volunteer .</brief_summary>
	<brief_title>A First In Human Study To Evaluate The Safety , Tolerability And Pharmacokinetics Of PF-04455242 In Single Rising Doses In Healthy Adult Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Bipolar Disorder</mesh_term>
	<criteria>Healthy male and/or female nonchildbearing potential age 18 55 year . Body Mass Index ( BMI ) approximately 18 30 kg/m2 ; total body weight &gt; 50 kg ( &gt; 110 lb ) . Willing able comply schedule visit , treatment plan , laboratory test , trial procedure . Evidence history clinically significant medical condition allergic disease ( include drug allergy , exclude untreated , asymptomatic , seasonal allergy time screen ) . Use tobacco nicotinecontaining product within 3 month screen positive urine blood cotinine screening . A positive urine drug screen . History regular alcohol consumption exceed 7 drinks/week female 14 drinks/week men .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>healthy volunteer , first human , safety tolerability</keyword>
</DOC>